179 related articles for article (PubMed ID: 33230026)
1. Efficacy of cariprazine in bipolar I depression across patient characteristics: a post hoc analysis of pooled randomized, placebo-controlled studies.
Patel M; Jain R; Tohen M; Maletic V; Earley WR; Yatham LN
Int Clin Psychopharmacol; 2021 Mar; 36(2):76-83. PubMed ID: 33230026
[TBL] [Abstract][Full Text] [Related]
2. Broad Efficacy of Cariprazine on Depressive Symptoms in Bipolar Disorder and the Clinical Implications.
Yatham LN; Vieta E; McIntyre RS; Jain R; Patel M; Earley W
Prim Care Companion CNS Disord; 2020 Sep; 22(5):. PubMed ID: 32942346
[TBL] [Abstract][Full Text] [Related]
3. Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies.
McIntyre RS; Suppes T; Earley W; Patel M; Stahl SM
CNS Spectr; 2020 Aug; 25(4):502-510. PubMed ID: 31576791
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of cariprazine in patients with bipolar depression and higher or lower levels of baseline anxiety: a pooled post hoc analysis.
Jain R; McIntyre RS; Cutler AJ; Earley WR; Nguyen HB; Adams JL; Yatham LN
Int Clin Psychopharmacol; 2024 Mar; 39(2):82-92. PubMed ID: 37551609
[TBL] [Abstract][Full Text] [Related]
5. Cariprazine for the treatment of bipolar mania with mixed features: A post hoc pooled analysis of 3 trials.
McIntyre RS; Masand PS; Earley W; Patel M
J Affect Disord; 2019 Oct; 257():600-606. PubMed ID: 31344528
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 study.
Earley WR; Burgess MV; Khan B; Rekeda L; Suppes T; Tohen M; Calabrese JR
Bipolar Disord; 2020 Jun; 22(4):372-384. PubMed ID: 31628698
[TBL] [Abstract][Full Text] [Related]
7. Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study.
Earley W; Burgess MV; Rekeda L; Dickinson R; Szatmári B; Németh G; McIntyre RS; Sachs GS; Yatham LN
Am J Psychiatry; 2019 Jun; 176(6):439-448. PubMed ID: 30845817
[TBL] [Abstract][Full Text] [Related]
8. Clinically relevant response and remission outcomes in cariprazine-treated patients with bipolar I disorder.
Earley W; Durgam S; Lu K; Ruth A; Németh G; Laszlovszky I; Yatham LN
J Affect Disord; 2018 Jan; 226():239-244. PubMed ID: 29017067
[TBL] [Abstract][Full Text] [Related]
9. An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression.
Durgam S; Earley W; Lipschitz A; Guo H; Laszlovszky I; Németh G; Vieta E; Calabrese JR; Yatham LN
Am J Psychiatry; 2016 Mar; 173(3):271-81. PubMed ID: 26541814
[TBL] [Abstract][Full Text] [Related]
10. A pooled post hoc analysis evaluating the safety and tolerability of cariprazine in bipolar depression.
Earley WR; Burgess M; Rekeda L; Hankinson A; McIntyre RS; Suppes T; Calabrese JR; Yatham LN
J Affect Disord; 2020 Feb; 263():386-395. PubMed ID: 31969269
[TBL] [Abstract][Full Text] [Related]
11. Effects of cariprazine on reducing symptoms of irritability, hostility, and agitation in patients with manic or mixed episodes of bipolar I disorder.
Citrome L; Li C; Yu J; Kramer K; Nguyen HB
J Affect Disord; 2024 Aug; 358():353-360. PubMed ID: 38657773
[TBL] [Abstract][Full Text] [Related]
12. Early improvement with cariprazine as a predictor of antidepressant, anxiolytic, and antimanic response in bipolar I mania and depression: A pooled post hoc analysis of randomized cariprazine trials.
Tohen M; Yu J; Kramer K; Nguyen HB
J Affect Disord; 2024 Jun; ():. PubMed ID: 38942209
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial.
Yatham LN; Vieta E; Earley W
Int Clin Psychopharmacol; 2020 May; 35(3):147-156. PubMed ID: 32058426
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of MADRS severity thresholds in patients with bipolar depression.
Thase ME; Harrington A; Calabrese J; Montgomery S; Niu X; Patel MD
J Affect Disord; 2021 May; 286():58-63. PubMed ID: 33677183
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of cariprazine on function in patients with bipolar depression: a
Vieta E; Calabrese JR; Whelan J; Tohen M; Earley WR
Curr Med Res Opin; 2021 Sep; 37(9):1635-1643. PubMed ID: 34034612
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study.
Calabrese JR; Keck PE; Starace A; Lu K; Ruth A; Laszlovszky I; Németh G; Durgam S
J Clin Psychiatry; 2015 Mar; 76(3):284-92. PubMed ID: 25562205
[TBL] [Abstract][Full Text] [Related]
17. Cariprazine for bipolar depression: What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome L
Int J Clin Pract; 2019 Oct; 73(10):e13397. PubMed ID: 31355510
[TBL] [Abstract][Full Text] [Related]
18. Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial.
Sachs GS; Greenberg WM; Starace A; Lu K; Ruth A; Laszlovszky I; Németh G; Durgam S
J Affect Disord; 2015 Mar; 174():296-302. PubMed ID: 25532076
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial.
Durgam S; Starace A; Li D; Migliore R; Ruth A; Németh G; Laszlovszky I
Bipolar Disord; 2015 Feb; 17(1):63-75. PubMed ID: 25056368
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of cariprazine in the treatment of acute bipolar I mania: A pooled post hoc analysis of 3 phase II/III studies.
Earley W; Durgam S; Lu K; Debelle M; Laszlovszky I; Vieta E; Yatham LN
J Affect Disord; 2017 Jun; 215():205-212. PubMed ID: 28343051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
